NCT02144077 - Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy | Biotech Hunter

Enrollment

281

Participants

Timeline

Start Date

January 28, 2014

Primary Completion Date

November 17, 2015

Study Completion Date

September 9, 2020

Conditions

Basal Cell Carcinoma (BCC)

Interventions

DRUG

BF-200 ALA

Topical treatment for photodynamic therapy combining drug application and subsequent illumination with a narrow spectrum light source (after 3 h of drug incubation)

DRUG

methyl-aminolevulinate

Topical treatment for photodynamic therapy combining drug application and subsequent illumination with a narrow spectrum light source (after 3 h of drug incubation)

Trial Locations (1)

45657

Klinikum Vest GmbH, Recklinghausen